06 mar: Aktietilbagekøbsprogram på DKK 400 mio. igangsættes
06 mar: Investeringsselskabet Artha Optimum A/S – optagelse til handel af..
06-03-2019 14:25:00

Investor Expectations to Drive Momentum within Amarin, PulteGroup, LivaNova, Teva Pharmaceutical Industries, Viad, and Activision Blizzard — Discovering Underlying Factors of Influence

NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC (NASDAQ:AMRN), PulteGroup, Inc. (NYSE:PHM), LivaNova PLC (NASDAQ:LIVN), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Viad Corp (NYSE:VVI), and Activision Blizzard, Inc (NASDAQ:ATVI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AMRN DOWNLOAD: https://Capital-Review.com/register/?so=AMRN

PHM DOWNLOAD: https://Capital-Review.com/register/?so=PHM

LIVN DOWNLOAD: https://Capital-Review.com/register/?so=LIVN

TEVA DOWNLOAD: https://Capital-Review.com/register/?so=TEVA

VVI DOWNLOAD: https://Capital-Review.com/register/?so=VVI

ATVI DOWNLOAD: https://Capital-Review.com/register/?so=ATVI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Amarin Corporation PLC (NASDAQ:AMRN), PulteGroup, Inc. (NYSE:PHM), LivaNova PLC (NASDAQ:LIVN), Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Viad Corp (NYSE:VVI), and Activision Blizzard, Inc (NASDAQ:ATVI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice:

the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 4th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AMARIN CORPORATION PLC (AMRN) REPORT OVERVIEW

Amarin's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Amarin reported revenue of $77.33MM vs $53.87MM (up 43.56%) and analysts estimated basic earnings per share -$0.11 vs -$0.08. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Amarin reported revenue of $229.21MM vs $181.10MM (up 26.56%) and analysts estimated basic earnings per share -$0.39 vs -$0.25. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is $0.25 and is expected to report on February 26th, 2020.

To read the full Amarin Corporation PLC (AMRN) report, download it here: https://Capital-Review.com/register/?so=AMRN

-----------------------------------------

PULTEGROUP, INC. (PHM) REPORT OVERVIEW

PulteGroup's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, PulteGroup reported revenue of $2,999.15MM vs $2,794.89MM (up 7.31%) and analysts estimated basic earnings per share $0.84 vs $0.25 (up 236.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, PulteGroup reported revenue of $10,188.33MM vs $8,577.69MM (up 18.78%) and analysts estimated basic earnings per share $3.56 vs $1.45 (up 145.52%). Analysts expect earnings to be released on April 23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $3.32 and is expected to report on February 4th, 2020.

To read the full PulteGroup, Inc. (PHM) report, download it here: https://Capital-Review.com/register/?so=PHM

-----------------------------------------

LIVANOVA PLC (LIVN) REPORT OVERVIEW

LivaNova's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, LivaNova reported revenue of $272.08MM vs $251.25MM (up 8.29%) and analysts estimated basic earnings per share -$0.15 vs $0.58. For the twelve months ended December 31st, 2017 vs December 31st, 2016, LivaNova reported revenue of $1,012.28MM vs $964.86MM (up 4.91%) and analysts estimated basic earnings per share -$0.52 vs -$1.29. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $3.62 and is expected to report on February 26th, 2020.

To read the full LivaNova PLC (LIVN) report, download it here: https://Capital-Review.com/register/?so=LIVN

-----------------------------------------

TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA) REPORT OVERVIEW

Teva Pharmaceutical Industries' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Teva Pharmaceutical Industries reported revenue of $4,559.00MM vs $5,398.00MM (down 15.54%) and basic earnings per share -$2.88 vs -$11.41. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Teva Pharmaceutical Industries reported revenue of $18,854.00MM vs $22,385.00MM (down 15.77%) and analysts estimated basic earnings per share -$2.35 vs -$16.26. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.91. The estimated EPS forecast for the next fiscal year is $2.56 and is expected to report on February 12th, 2020.

To read the full Teva Pharmaceutical Industries Ltd. (TEVA) report, download it here: https://Capital-Review.com/register/?so=TEVA

-----------------------------------------

VIAD CORP (VVI) REPORT OVERVIEW

Viad's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Viad reported revenue of $296.92MM vs $277.29MM (up 7.08%) and analysts estimated basic earnings per share -$0.12 vs -$1.06. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Viad reported revenue of $1,296.18MM vs $1,306.97MM (down 0.82%) and analysts estimated basic earnings per share $2.40 vs $2.83 (down 15.19%). Analysts expect earnings to be released on April 25th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.49. The estimated EPS forecast for the next fiscal year is $3.55 and is expected to report on February 6th, 2020.

To read the full Viad Corp (VVI) report, download it here: https://Capital-Review.com/register/?so=VVI

-----------------------------------------

ACTIVISION BLIZZARD, INC (ATVI) REPORT OVERVIEW

Activision Blizzard's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Activision Blizzard reported revenue of $2,382.00MM vs $2,042.00MM (up 16.65%) and analysts estimated basic earnings per share $0.85 vs -$0.78. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Activision Blizzard reported revenue of $7,500.00MM vs $7,017.00MM (up 6.88%) and analysts estimated basic earnings per share $2.38 vs $0.36 (up 561.11%). Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.34. The estimated EPS forecast for the next fiscal year is $2.59 and is expected to report on February 11th, 2020.

To read the full Activision Blizzard, Inc (ATVI) report, download it here: https://Capital-Review.com/register/?so=ATVI

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:

Nicole Garrens, Media Department

Office: +1 (410) 280-7496

E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Relateret indhold
11 feb - 
Vestas stråler i C25 - USA blandet fra start
Relateret debat
20 jun - 
Du skal da kun være glad for du betaler skat, og jo mer..
14 jun - 
kunne være bange for KS snart er historik..
14 jun - 
ligesom vores eget skattesystem er rådent, så er USA su..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Mærsk lancerer nyt onlineprodukt: Vil bryde med overbookinger

25-06-2019 10:36:22
(Korr: ændring i andet afsnit. Ordet "betales" er ændret til "aftales".)A.P. Møller-Mærsk lancerer et nyt onlineprodukt, der skal være med til at gøre transporten af containere mere simpel for kunderne, og som samtidig kan være med til at undgå overbookinger.Produktet går under navnet Maersk Spot, og det sikrer kunderne en garanti for, at fragten bliver lastet, skriver Mærsk i en pressemeddelelse ..

Aktier/tendens: Inspirationen hælder mest til den negative side

25-06-2019 08:15:21
Aktiehandlerne får ændrede kursmål for Chr. Hansen, Ambu, Danske Bank og Carlsberg samt en kontrakt til Maersk Drilling som selskabsspecifikke C25-nyheder til inspiration for den indledende handel tirsdag morgen.To af de fire kursmålsændringer er til den negative side, og det samme er den generelle impuls fra de globale markeder. Der var fald i USA i mandagens handel, og den negative udvikling er ..

Euroinvestor spørger: Tryg-aktien stormer frem, kan den blive ved?

23-06-2019 20:35:00
Hos Euroinvestor mener vi, at den bedste kilde til viden om markedet er aktørerne i markedet.Derfor spørger vi hver måned i vores Privatinvestorundersøgelse (PIU) vores brugere om deres forventninger til markeder og økonomi.Du inviteres hermed til at deltage i undersøgelsen. Alle besvarelser er anonyme, og der er ingen krav om login, kontaktoplysninger eller lignende.Vi håber du vil deltage og ser..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Sydbank: Spansk konkurrent er foran på point i kampen
2
Danske Bank/Nordea: Sænker kursmål med 10 kr.
3
Danske Bank/Erhvervsminister undersøger straf for dårlige råd
4
USA: Trump kræver rentenedsættelser og langer igen ud efter Fed
5
Mandagens aktier: Ørsted til vejrs på USA-nyt i svagt negativt marked

Relaterede aktiekurser

Teva Pharmaceutical Indu.. 8,250 -2,4% Fald i aktiekurs
Amarin Corporation plc -.. 18,42 -3,1% Fald i aktiekurs
PulteGroup Inc 32,15 0,8% Stigning i aktiekurs
Viad Corp 66,14 -0,2% Fald i aktiekurs
Activision Blizzard Inc 47,15 2,7% Stigning i aktiekurs
LivaNova PLC - Ordinary .. 73,79 -0,3% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. juni 2019 12:23:44
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 12:23:44 - 2019-06-25 12:23:44 - 1 - Website: OKAY